𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy

✍ Scribed by José F. Flores; Robert K. Rude; Robert A. Chapman; Chandra P. Belani; Alex Y-C Chang; James D. Pritchard; Julie V. Hoff

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
675 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with 24 hours continuous venous infusion of dacarbazine and cisplatin
✍ Fikri Icli; Handan Karaoguz; Dilek Dincol; Nazan Gunel; Ahmet Demirkazik 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Twenty consecutive patients with metastatic malignant melanoma were treated with a combination of 24 hours continuous infusion of dacarbazine (250 mg/m2) and cisplatin (20 mg/m2) for 5 days every 3 weeks. One patient (5%) achieved a complete response (CR) and 3 patients (15%) obtained a partial resp

A randomized phase 2 trial comparing 3-h
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
✍ Stacy L. Moulder; Frankie A. Holmes; Anthony W. Tolcher; Peter Thall; Kristine B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract ## BACKGROUND: This study was performed to compare efficacy and toxicity profiles of paclitaxel using 3‐hour versus 96‐hour infusion schedules. ## METHODS: Patients with metastatic breast cancer (MBC) were randomly assigned to receive paclitaxel starting at a dose of 250 mg/m^2^ intr

Cis-diamminedichloroplatinum (II) admini
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer
✍ Edward T. Creagan; Judith R. O'Fallon; John E. Woods; James N. Ingle; Allan J. S 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

A regression rate of 12% (4/33) among patients with advanced upper aerodigestive carcinomas who received an intravenous regimen of cis-diamminedichloroplatinum, 90 mg/mz/24 hours each three weeks was achieved. The response rate was 13% (3/23) among patients with typical squamous cell carcinoma. Most